sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
8-Feb-2016 12:14
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 326-350 out of 1152.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>

Public Release: 7-Jul-2015
Nature Communications
Study identifies new way to kill the malaria parasite
The discovery could pave the way to new treatments for the disease.
Medical Research Council, Wellcome Trust

Contact: MRC press office
University of Leicester

Public Release: 6-Jul-2015
Study explains how dengue virus adapts as it travels, increasing chances for outbreaks
A researcher from The University of Texas Medical Branch at Galveston is an integral member of a collaborative group that is the first to explain the mechanisms that the Dengue virus has developed to optimize its ability to cause outbreaks as it travels across the globe to new places and revisits old ones.
The Singapore National Medical Research Council, Ministry of Health in Singapore, Institute of Molecular and Cell Biology, Agency of Science, Technology and Research in Singapore, National Institutes of Health

Contact: Donna Ramirez
University of Texas Medical Branch at Galveston

Public Release: 6-Jul-2015
New blood pressure guidelines may lead to under treatment of older adults
In 2014, the Joint National Committee released the eighth update to the blood pressure guidelines (JNC8P). These guidelines included a controversial decision to change the blood pressure goal that may lead to under treatment of adults 60 years of age or older. The JNC8P guidelines set a less stringent goal blood pressure of < 150/90 mmHg for individuals 60 years of age or older compared to the previous <140/90 mmHg goal.

Contact: Melissa Hanson
Minneapolis Heart Institute Foundation

Public Release: 6-Jul-2015
Safer, with more benefits: Parents' vaccine views shifting
Over the same time period that multiple outbreaks of measles and whooping cough made headlines around the country, parents' views on vaccines became more favorable.

Contact: Beata Mostafavi
University of Michigan Health System

Public Release: 2-Jul-2015
PLOS Neglected Tropical Diseases
Rope-chewing technique an easy way to screen monkeys for disease
What a piece of rope and strawberry jam have to do with preventing the spread of zoonotic disease.
USAID Emerging Pandemic Threats Program, William J. Fulbright Fellowship

Contact: Tierra Smiley Evans
University of California - Davis

Public Release: 2-Jul-2015
The Lancet
Millions of children's lives saved through low-cost investments
More than 34 million children's lives have been saved since 2000 because of investments in child health programs at a cost of as little as $4,205 per child, according to a new analysis in The Lancet. From 2000 to 2014, low- and middle-income country governments spent $133 billion on child health. Donors spent $73.6 billion. The governments saved about 20 million children, and the donors saved an additional 14 million children.

Contact: William Heisel
Institute for Health Metrics and Evaluation

Public Release: 2-Jul-2015
Mosquito-borne viruses subject of $4 million in federal grants to Pitt vaccine researchers
Scientists at the University of Pittsburgh Center for Vaccine Research recently received nearly $4 million through five federal grants to study a group of related mosquito-borne viruses. The ultimate goal is to develop vaccines and therapies against the deadly diseases.
National Institutes of Health, US Department of Defense

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 2-Jul-2015
Viral protein in their sights
A team from Harvard Medical School, using electron cryomicroscopy, has for the first time revealed at the atomic level the structure of a protein required for viral replication in vesicular stomatitis virus, a virus that is a model for a group of RNA viruses that includes Ebola and other threats to human health.
National Institutes of Health, New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases

Contact: David Cameron
Harvard Medical School

Public Release: 2-Jul-2015
Vanderbilt research could lead to vaccines and treatment for dengue virus
Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.
National Institutes of Health

Contact: Craig Boerner
Vanderbilt University Medical Center

Public Release: 2-Jul-2015
Human antibody blocks dengue virus in mice
Researchers have discovered that a human antibody specific to dengue virus serotype 2, called 2D22, protects mice from a lethal form of the virus -- and they suggest that the site where 2D22 binds to the virus could represent a potential vaccine target.

Contact: Natasha Pinol
American Association for the Advancement of Science

Public Release: 1-Jul-2015
Clinical Investigation
Clinical investigation reviews approaches and outcomes of Africa-based HIV trials
A new article in Clinical Investigation highlights the learnings gleaned from monitoring several complex HIV clinical trials in Africa over a 15 year period.

Contact: Leela Ripton
Future Science Group

Public Release: 1-Jul-2015
BMC Public Health
Stunting remains a challenge in SA
Stunting remains stubbornly persistent in South Africa, despite economic growth, political and social transitions, and national nutritional programs, says a Wits-led research team. Stunting refers to a reduced growth size in human development and is a chronic form of undernutrition. This issue has several significant public health implications due to increased morbidity and mortality.

Contact: Kemantha Govender
University of the Witwatersrand

Public Release: 30-Jun-2015
A win-win-win-win
With $1.5 million in NSF funding, a group of researchers will study the effects of a novel way of eradicating schistosomiasis.
National Science Foundation

Contact: Sonia Fernandez
University of California - Santa Barbara

Public Release: 30-Jun-2015
Macy Foundation President's Grant supports refugee health education at Georgetown
The Josiah Macy Jr. Foundation has awarded a President's Grant to Georgetown family medicine physician Ranit Mishori, M.D., M.H.S., F.A.A.F.P., to create a comprehensive curriculum to educate health professions students, residents and clinicians about the health needs of immigrants, migrants, torture survivors, asylum seekers and refugees.
The Josiah Macy Jr. Foundation

Contact: Karen Teber
Georgetown University Medical Center

Public Release: 29-Jun-2015
Journal of Public Health
After Ebola, understanding health care needs among rural Liberians
As Liberia rebuilds a health care system decimated by the 2014 Ebola outbreak, understanding precisely how far citizens live from health facilities and its impact on seeking care can help shape new strategies to improve health care delivery and reduce geographic disparities.

Contact: Karen Teber
Georgetown University Medical Center

Public Release: 29-Jun-2015
Proceedings of the National Academy of Sciences
First-ever possible treatments for MERS
As the South Korean MERS epidemic continues, researchers have discovered and validated two therapeutics that show early promise in preventing and treating the disease, which can cause severe respiratory symptoms, and has a death rate of 40 percent.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 29-Jun-2015
Biological Chemistry
OU professor developing vaccine to protect global communities from malaria
An OU professor studying malaria mosquito interaction has discovered a new mosquito protein for the development of a vaccine that is expected to stop the spread of the disease in areas where it is considered endemic. Malaria is transmitted by mosquitoes, and it infects millions of people in Africa, Asia and South America every year, causing a global health crisis. Local populations, US military personnel stationed in these areas and travelers to these malaria-prone areas are at risk of becoming infected.
National Institutes of Health, National Science Foundation, Oklahoma Center for the Advancement of Science and Technology

Contact: Jana Smith
University of Oklahoma

Public Release: 29-Jun-2015
SLU's vaccine center awarded $2.9 million to study new TB vaccine
Daniel Hoft, M.D., Ph.D., director of the division of infectious diseases at Saint Louis University has received funding from the Gates Foundation to research a potential vaccine against tuberculosis.
Bill & Melinda Gates Foundation

Contact: Nancy Solomon
Saint Louis University

Public Release: 29-Jun-2015
PLOS Pathogens
TSRI and biotech partners find new antibody weapons against Marburg virus
A new study led by scientists at the Scripps Research Institute identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop treatments for future Marburg outbreaks.
NIH/National Institute of Allergy and Infectious Diseases, National Science Foundation, Japan Society for Promotion of Science, Uehara Memorial Foundation, Investigators in the Pathogenesis of Infectious Disease etc.

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 28-Jun-2015
Lancet Global Health
More secondary schooling reduces HIV risk
Longer secondary schooling substantially reduces the risk of HIV infection -- especially for girls -- and could be a very cost-effective way to halt the spread of the virus, according to researchers from Harvard T.H. Chan School of Public Health. In a study in Botswana, researchers found that, for each additional year of secondary school, students lowered their risk of HIV infection by 8 percentage points about a decade later, from 25 percent to about 17 percent infected.
Harvard T.H. Chan School of Public Health, Belgian American Educational Foundation, Fernand Lazard Foundation, Boston University, National Institutes of Health

Contact: Marge Dwyer
Harvard T.H. Chan School of Public Health

Public Release: 26-Jun-2015
Cell Reports
Scientists identify 'decoy' molecule that could help sharply reduce risk of flu death
The flu virus can be lethal. But what is often just as dangerous is the body's own reaction to the invader. The immune counterattack can end up harming the body's own tissues, causing deadly damage. Now, a University of Maryland School of Medicine researcher has for the first time uncovered new details about how this response plays out. And he has identified a 'decoy' molecule that can rein in this runaway inflammatory response.

Contact: David Kohn
University of Maryland School of Medicine

Public Release: 25-Jun-2015
Proceedings of the Royal Society B
Tracking the genetic arms race between humans and mosquitoes
Individual populations of mosquitoes are under strong evolutionary pressure from humans and their environment, a new study shows.
National Institutes of Health, Russian Science Ministry

Contact: Robert Perkins
University of Southern California

Public Release: 25-Jun-2015
University of Kentucky researcher to develop artificial blood for mosquitoes
A University of Kentucky professor's laboratory continues to advance research on controlling one of the world's most notorious species of pests, the mosquito.
Bill and Melinda Gates Foundation

Contact: Katie Pratt
University of Kentucky

Public Release: 25-Jun-2015
New report: Investments in neglected tropical diseases one of the best buys in development
A new report by Uniting to Combat NTDs highlights dramatic health and economic benefits from investing in combating neglected tropical diseases, making it one of the best buys in development. The report finds that countries are increasingly taking ownership of NTD programs, have started providing new funding and are pursuing innovative approaches to combat these devastating diseases. Yet, further scale-up is necessary to reach the World Health Organization 2020 targets.
Uniting to Combat Neglected Tropical Diseases

Contact: Dan Pawson
Global Health Strategies

Public Release: 25-Jun-2015
Veterinary Record
European rule changes on cross border pet transport may heighten rabies risk
Recent changes to regulations on the transport of pets across Europe may have increased the threat of introducing rabies from rescue dogs into countries considered free of the disease, suggests research published in Veterinary Record.

Contact: Caroline White

Showing releases 326-350 out of 1152.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>